Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. (KLDO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
kldo · pe ratio · data through Dec 31, 2021
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Kaleido Biosciences, Inc. (KLDO) measures how much investors pay for each dollar of the company's trailing earnings. KLDO's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$2.16.
Source: FMP · /ratios-ttm · /analyst-estimates · 2021-12-31
PE Ratio History
2016 – 2021 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Kaleido Biosciences, Inc.You KLDO | $0M | N/A | — | -$2.16 |
 Arno Therapeutics, Inc. ARNI | $0M | N/A | — | -$0.57 |
 Better Therapeutics, Inc. BTTX | $0M | N/A | — | -$1.69 |
 Baudax Bio, Inc. BXRXQ | $0M | N/A | — | -$177.30 |
 Calithera Biosciences, Inc. CALA | $0M | N/A | — | -$3.78 |
 Innovation1 Biotech Inc. IVBT | $0M | N/A | — | -$0.30 |
 Sienna Biopharmaceuticals, Inc. SNNAQ | $0M | N/A | — | -$3.59 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2021-12-31Latest FY2021 | — | $-2.16 | — | |
2020-12-31 FY2020 | — | $-2.44 | — | |
2019-12-31 FY2019 | — | $-3.31 | — | |
2018-12-31 FY2018 | — | $-2.10 | — | |
2017-12-31 FY2017 | — | $-1.23 | — | |
2016-12-31 FY2016 | — | $-0.43 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Kaleido Biosciences, Inc. (KLDO) measures how much investors pay for each dollar of the company's trailing earnings. KLDO's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$2.16.
Frequently asked questions
KLDO pe ratio · 6 questionsKLDO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$2.16. Data sourced from Financial Modeling Prep via KLDO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Kaleido Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08